Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

359
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
359
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

119
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
119

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Optimal dimensionality and fundamental limits of proton stopping power estimation with photon-counting CT material decomposition.

Physics in medicine and biology·2026
Same author

The Declaration of Adelaide White paper: Guidelines for Author Responsibility in Peer Review.

Journal of radiological protection : official journal of the Society for Radiological Protection·2026
Same author

Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Integrating biomarker-derived individual treatment response assessment into Bayesian trial design for personalized cancer treatment.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Spread-Out Bragg Peak FLASH Radiotherapy for Head and Neck Reirradiation: A Treatment Planning Study.

International journal of particle therapy·2026
Same author

Impact of center-to-center distance and slit width on robust target coverage and PVDR for proton minibeam radiation therapy using a commercial TPS.

Medical physics·2026

相关实验视频

Updated: May 3, 2026

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
12:48

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays

Published on: February 19, 2013

10.5K

基于"脏剂量"的质子变量RBE模型 - - 在体外数据上的性能评估.

Fredrik Kalholm1,2,3, Iuliana Toma-Dasu1,2, Erik Traneus3

  • 1Medical Radiation Physics, Department of Physics, Stockholm University, Stockholm, Sweden.

Medical physics
|November 20, 2024
PubMed
概括

这项研究引入了质子放射治疗的新"脏剂量"模型,简化了计算并提高了效率. 这种可变相对生物有效性 (RBE) 模型的性能与现有方法相提并论,为未来的RBE建模提供了一种实用方法.

关键词:
让我们来看看它.在RBE中,RBE就是RBE.脏的剂量是一个脏的剂量.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

相关实验视频

Last Updated: May 3, 2026

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
12:48

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays

Published on: February 19, 2013

10.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

科学领域:

  • 医学物理 医学物理
  • 辐射瘤学 辐射瘤学
  • 放射生物学的放射生物学

背景情况:

  • 临床质子辐射疗法通常使用1.1的恒定相对生物效率 (RBE).
  • 实验室研究显示RBE效应可变,导致提出的模型将RBE参数与剂量平均线性能量转移 (LET) 联系起来.

研究的目的:

  • 介绍一个基于RBE模型的新型变量.
  • 脏的剂量是一个脏的剂量.
  • 一个概念,一个概念.
  • 简化质子疗法中的计算和实验评估,重点关注超出特定 LET 值的 voxels 内剂量.

主要方法:

  • 利用已公布的细胞存活率,剂量和LET的体外数据.
  • 重新模拟实验设置以提取脏剂量指标.
  • 通过RMSE开发和对比使用污染剂量分数与传统辐射质量指标的LQ模型.

主要成果:

  • 基于污染剂量的模型显示性能与传统指标相比,RMSE为0.38,为7 γ值.
  • 较高的 LET 值通常会改善模型性能.
  • 基于LET (γ) 和剂量平均LET (γ) 的模型显示RMSE分别为0.42和0.36.

结论:

  • 使用污染剂量指标的可变RBE模型与当前辐射质量指标相提并论.
  • 简化的计算和有效的实验验证的潜力使得脏剂量模型成为未来质子RBE建模的实用和保守的选择.